Oxipit Awarded CE Mark for the First Autonomous AI Medical Imaging Application

AI medical imaging application developer Oxipit was granted CE Class IIb certification for ChestLink autonomous AI imaging suite. The application autonomously reports on chest X-rays featuring no abnormalities without any involvement from a radiologist. It is the first regulatory approved AI medical imaging application to perform diagnostics autonomously. - March 31, 2022

Oxipit to Offer Free of Charge Retrospective CXR Quality Audit at RSNA

At the annual RSNA meeting, the AI medical imaging company will present the new ChestEye Quality AI double reading tool. To showcase vanguard ChestEye Quality capabilities, Oxipit will offer a free-of-charge quality audit for 6 months of retrospective CXR data. - November 26, 2021

Oxipit Expands Executive Team with a New Chief Commercial Officer

AI medical imaging company Oxipit appointed Dany Chammas as their new Chief Commercial Officer. With more than 15 years of experience in top tier medical imaging companies, Dany will join the Executive Team to increase Oxipit’s visibility and accelerate business growth. - October 07, 2021

Oxipit to Preview First Autonomous AI Medical Imaging Application at ECR

The AI medical imaging company will showcase the first autonomous AI diagnostics application for healthy patient report automation. The new product by Oxipit automatically identifies chest X-ray images with no abnormality and produces finalized patient reports without any intervention from the radiologist. The application is pending CE mark certification and will be made available for commercial deployments in the Q3 2021. - March 04, 2021

Oxipit and Parasmed Partnership to Extend CXR AI Product Distribution in Eastern Africa

Medical imaging company Oxipit announced partnership with Parasmed, a Nairobi-based medical healthcare solutions distributor in Eastern Africa. With recent partnerships in Nigeria and strong foothold in Latin America, the new agreement is an important step towards creating a global, locally present network of Oxipit software distributors. - January 14, 2021

TeleradiologĂ­a de Colombia Partners with Oxipit for Chest X-Ray AI Diagnostics

Teleradiologia de Colombia, a leading diagnostic imaging services provider in Latin America, is rolling out Oxipit AI solutions across its network. Oxipit AI suite will produce preliminary chest X-Ray reports and identify healthy patient images with no abnormalities, augmenting radiologist productivity and improving radiologist workflow. It marks the first Oxipit deployment in Colombia with more announcements in Latin America coming soon. - August 26, 2020

Oxipit Receives Patent for Improved AI Lung Cancer Diagnostics

Oxipit, creators of artificial intelligence based radiology imaging suite ChestEye, announces that the European Patent Office has approved their patent application. The innovation allows efficient use of high-resolution chest X-ray images for machine learning model training and is especially relevant for improving lung nodule detection. - May 27, 2020

Oxipit ChestEye Secures Medical Device Certification in Australia

The AI medical imaging company has received an Australian Register of Therapeutic Goods Class IIa medical device certificate for ChestEye AI imaging service. Medical device certification paves the way for clinical use of ChestEye in the Australian market. ChestEye imaging suite is already certified by the CE mark. Oxipit received CE certification last February, enabling clinical ChestEye deployment in 32 European countries. - March 07, 2020

New Oxipit Service to Aid Large Scale Chest X-Ray Screening Projects

The AI medical imaging company will showcase ChestEye Negative service at Arab Health 2020 conference in Dubai. ChestEye Negative produces preliminary reports for chest X-rays with no abnormality. The service aims to reduce the workload of radiologists, especially in clinical environments, where only a fraction of all studies features an abnormality. It also significantly simplifies large-scale medical screening projects. - January 31, 2020

Oxipit to Showcase AI X-Ray Longitudinal Comparison at RSNA

The AI medical imaging company will offer a first public preview of Dynamics feature for its award winning ChestEye CAD suite. Dynamics enables a radiologist to compare X-rays and provide automatically generated reports specifically addressing the changes in images over the course of patient treatment. - December 08, 2019

Study: AI Found to Reduce Bias in Radiology Reports

A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics (CARING) found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions. The study was undertaken using Oxipit ChestEye AI imaging suite. - November 28, 2019

Medical Imaging Company Oxipit Raises $1.7m Seed Round to Bring AI Into Clinical Radiology Practice

Oxipit are the authors of ChestEye AI-powered radiology software suite. Automated AI-based diagnosis and reporting by ChestEye enables radiologists to improve productivity, reduce error-rate, discover overlooked secondary findings and address the shortage and ever-increasing workload of radiology specialists. - July 24, 2019

Press Releases 1 - 12 of 12